Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
STOCKHOLM, SVERIGE 28 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Umecrine Cognition presenterat nya prekliniska resultat som ger ytterligare...
-
STOCKHOLM, SWEDEN – September 28, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has presented new preclinical results that...
-
STOCKHOLM, SVERIGE 27 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Modus Therapeutics har slutfört rekryteringen till bolagets kliniska fas...
-
STOCKHOLM, SWEDEN September 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Modus Therapeutics has completed the recruitment in a clinical phase...
-
STOCKHOLM, SVERIGE 14 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Umecrine Cognition har säkrat finansiering med 41 miljoner kronor inför...
-
STOCKHOLM, SWEDEN – September 14, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the portfolio company Umecrine Cognition has secured funding of SEK 41 million for the...
-
STOCKHOLM, SVERIGE 7 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio tagit in 150 miljoner SEK i en serie A-finansieringsrunda från en...
-
STOCKHOLM, SWEDEN September 7, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has completed a series A investment round of SEK 150...
-
STOCKHOLM, SVERIGE 6 september 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att Hans Christopher ”HC” Toll har rekryterats till positionen som finansdirektör. Han tillträder...
-
STOCKHOLM, SWEDEN, September 6, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the company has recruited Hans Christopher “HC” Toll to the position of Chief Financial...